Meditor Group’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2013
Q3
Sell
-144,647
Closed -$4.48M 37
2013
Q2
$4.48M Buy
+144,647
New +$4.48M 0.61% 25